Systemic delivery of genes to striated muscles using adeno-associated viral vectorsPaul Gregorevic, Jeffrey S. Chamberlain, Michael J. Blankinship et al.|Nature Medicine|2004Cited by 611
High levels of AAV vector integration into CRISPR-induced DNA breaksKillian S. Hanlon, Bence György, Adrienn Volak et al.|Nature Communications|2019Cited by 430
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophyNiclas E. Bengtsson, Jeffrey S. Chamberlain|Nature Communications|2017Cited by 383
MULTIPLEX PCR FOR THE DIAGNOSIS OF DUCHENNE MUSCULAR DYSTROPHYJeffrey S. Chamberlain, C. Thomas Caskey, Richard A. Gibbs et al.|Elsevier eBooks|1990Cited by 227
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M. Birch, Joe N. Kornegay, Michael W. Lawlor et al.|Science Translational Medicine|2023Cited by 68